Vertebro-basilar occlusive disease

• Autores: J. Taylor, J. A. Brizuela, Borja Merino Díaz, María Victoria Gastambide, I. Estévez, R. Fuente, Carlos Vaquero Puerta
• Localización: Revista española de investigaciones quirúrgicas, ISSN 1139-8264, Vol. 16, Nº. 1, 2013, págs. 37-41
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Vertebro-basilar occlusive disease is a condition that can cause symptomatology related to encephalic posterior circulation ischemia.

    Vertebro-basilar (VB) ischemia represents a 25% of all TIA�s and Strokes in North America (1). In a patient with a VB-TIA, if vertebro-basilar (VB) pathology is demonstrated, he or she will have a 30-35% risk of having a VB circulation stroke in the next 5 years (2); demonstrating that vertebro-basilar occlusive disease is a relevant condition regarding mortality, morbidity and health-related costs.

    Since Crawford and colleagues described the trans-subclavian vertebral artery endarterectomy by the end of the 50�s, vertebro-basilar occlusive disease has been studied rather little.

    We pretend to do a revision of this disease, and to discuss briefly the most up-to-date therapies described in current literature for this condition.